Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Looking for Passive Income? Try This Monster Stock

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

StockNews.com

An epidemic of fentanyl misinformation

More politicians say fentanyl should be deemed a "weapon of mass destruction." Do they even understand what it is?

Salon

Europe OK's 1st one-dose drug to protect babies against RSV

The European Commission has authorized the world’s first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

‘Vaccine apathy’ slowing down London’s Covid booster rollout

Top health professor warns that over-50s in London must be better protected heading into winter

Evening Standard

Healthtech and sustainable start-ups win Scottish innovation awards

Rebecca Goss from the University of St Andrews, who founded X-Genix, takes overall prize

Insider UK

Pfizer study says updated COVID boosters rev up protection

Pfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies

The Independent UK

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

China to make 'substantial' COVID policy changes soon - ex-govt expert

China will make substantial changes to its "dynamic-zero" COVID-19 policy in coming months, a former Chinese disease control official told a conference hosted by Citi on Friday, according to a recording of the session heard by Reuters.

Reuters

China's COVID policies are consistent and clear - China foreign ministry

Chinese foreign ministry spokesman Zhao Lijian said on Friday that he was not aware of the media report that said China was preparing a plan to end COVID-19 flight suspensions.

Reuters

General Mills latest to halt Twitter ads as Musk takeover sparks brand exodus

Cheerios and Lucky Charms cereal company joins General Motors Co and Audi among others in pulling money from the platform

The Guardian - US

All the latest COVID-19 news and case numbers from around the states and territories

Here's a quick wrap of the COVID-19 news and case numbers from each Australian jurisdiction from the past week.

ABC News

US agency softens opioid prescribing guidelines for doctors

The nation’s top public health agency has revised its guidelines for U.S. doctors prescribing oxycodone and other opioid painkillers

The Independent UK

New York could get $524M under opioid settlements with Teva

New York Attorney General Letitia James says the state will receive up to $524 million from drugmaker Teva to settle claims that the company contributed to the U.S. opioid epidemic

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Reuters

Pfizer, BioNTech start COVID-flu combination vaccine study

U.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.

The Independent UK

Pfizer starts early-stage trial of combined Covid and flu vaccine

The trial will look at the safety of the combined jab, how effective it is and whether patients suffer any side-effects

Wales Online

Pfizer trying a jab which protects against flu and Covid

The drug is being tested on 180 people aged 18 to 64

The Independent UK

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

Orlando Sentinel

Ketamine ‘saved my life’: Depressed, anxious Floridians turn to unregulated psychadelics

ORLANDO, Fla. — Ashley Blanco, 27, has grappled with anxiety, depression and obsessive-compulsive disorder for the better part of a decade. Antidepressants and therapy didn’t help. After she graduated college, the COVID-19 pandemic hit. It sent her mental health to an all-time low.

France 24

US pharmacies announce opioid settlements totaling $10 billion

The two largest US pharmacy chains, CVS Health and Walgreen Co., announced agreements in principle on Wednesday to pay about $5 billion each to settle lawsuits nationwide over the toll of opioids, and a lawyer said Walmart, a third pharmacy behemoth, is in discussions for a deal.

The National (Scotland)

Tory MP previously flagged for outside jobs made Health Select Committee chair

A TORY MP who was flagged by a lobbying watchdog over external jobs with pharma companies has been made the chair of the Health Select Committee.

ABC News

Almost two-thirds of Australians — including children — have had COVID-19, blood study suggests

Research suggesting almost two-thirds of Australians have had COVID-19 comes via blood studies from the National Centre for Immunisation Research and Surveillance.

Benzinga

Psychedelics Company's $60M Series A For Startup To Develop Treatment For Mental Health Disorders

Biotech company focused on creating next-gen serotonergic neuroplastogen psychedelic compounds to treat severe neuropsychiatric and neurological conditions Lusaris Therapeutics launched with a $60 million Series A financing.

1 … 105 106 107 108

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations